References
- Addington, D., Addington, J., Maticka-Tyndale, E., & Joyce, J. (1992). Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research, 6(3), 201–208. https://doi.org/https://doi.org/10.1016/0920-9964(92)90003-N
- Addington, D., Addington, J., & Schissel, B. (1990). A depression rating scale for schizophrenics. Schizophrenia Research, 3(4), 247–251. http://www.sciencedirect.com/science/article/pii/092099649090005R.
- Amri, I., Millier, A., & Toumi, M. (2014). Minimum clinically important difference in the global assessment functioning in patients with schizophrenia. Value in Health, 17(7), A765–766. https://doi.org/https://doi.org/10.1016/j.jval.2014.08.285
- Andresen, R., Caputi, P., & Oades, L. (2006). Stages of recovery instrument: Development of a measure of recovery from serious mental illness. Australian and New Zealand Journal of Psychiatry, 40(11–12), 972–980. https://doi.org/https://doi.org/10.1111/j.1440-1614.2006.01921.x
- Andresen, R., Caputi, P., & Oades, L. G. (2010). Do clinical outcome measures assess consumer-defined recovery? Psychiatry Research, 177(3), 309–317. http://www.sciencedirect.com/science/article/pii/S0165178110000594.
- Beck, R., Heffernan, S., Law, H., McCusker, M., Bentall, R. P., & Morrison, A. P. (2012). Subjective judgements of perceived recovery from psychosis. Journal of Mental Health, 21(6), 556–566. https://doi.org/https://doi.org/10.3109/09638237.2012.710765
- Bell, M., Milstein, R., Beam-Goulet, J., Lysaker, P., & Cicchetti, D. (1992). The positive and negative syndrome scale and the brief psychiatric rating scale: Reliability, comparability, and predictive validity. Journal of Nervous and Mental Disease, 180(11), 723–728. https://doi.org/https://doi.org/10.1097/00005053-199211000-00007
- Cohen, J. (1988). Statistical power analysis for the behavioural sciences (2nd ed.). Lawrence Erlbaum Assosciates.
- Cook, J. A., Hislop, J., Adewuyi, T. E., Harrild, K., Altman, D. G., Ramsay, C. R., Fraser, C., Buckley, B., Fayers, P., Harvey, I., Briggs, A., Norrie, J., Fergusson, D., Ford, I., & Vale, L. D. (2014). Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review. Health Technology Assessment, 18(28), v–vi, 1–175. https://doi.org/https://doi.org/10.3310/hta18280
- Corrigan, P., Giffort, D., Rashid, F., Leary, M., & Okeke, I. (1999). Recovery as a psychological construct. Community Mental Health Journal, 35, 231–239. https://doi.org/https://doi.org/10.1023/a:1018741302682
- Forkmann, T., Scherer, A., Boecker, M., Pawelzik, M., Jostes, R., & Gauggel, S. (2011). The clinical global impression scale and the influence of patient or staff perspective on outcome. BMC Psychiatry, 11(1), 83. https://doi.org/https://doi.org/10.1186/1471-244X-11-83
- Guy, W. (1976). Assessment manual for psychopharmacology. US Department of Heath, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration.
- Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K. W., & Norman, G. R. (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings, 77(4), 371–383. https://doi.org/https://doi.org/10.4065/77.4.371
- Hermes, E. D. A., Sokoloff, D. M., Stroup, T. S., & Rosenheck, R. A. (2012). Minimum clinically important difference in the positive and negative syndrome scale with data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE). The Journal of Clinical Psychiatry, 73(4), 526–532. https://doi.org/https://doi.org/10.4088/JCP.11m07162
- Johnston, B. C., Ebrahim, S., Carrasco-Labra, A., Furukawa, T. A., Patrick, D. L., Crawford, M. W., Hemmelgarn, B. R., Schunemann, H. J., Guyatt, G. H., & Nesrallah, G. (2015). Minimally important difference estimates and methods: A protocol. BMJ Open, 5(10), e007953. https://doi.org/https://doi.org/10.1136/bmjopen-2015-007953
- Kawata, A. K., & Revicki, D. A. (2008). Psychometric properties of the Personal and Social Performance scale (PSP) among individuals with schizophrenia living in the community. Quality of Life Research, 17(10), 1247–1256. https://doi.org/https://doi.org/10.1007/s11136-008-9400-z
- Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276. https://doi.org/https://doi.org/10.1093/schbul/13.2.261
- Kay, S. R., Opler, L. A., & Fiszbein, A. (1988). Reliability and validity of the Positive and Negative Syndrome Scale for schizophrenics. Psychiatry Research, 23(1), 276–286. https://doi.org/https://doi.org/10.1016/0165-1781(88)90038-8
- Landorf, K. B., & Radford, J. A. (2008). Minimal important difference: Values for the foot health status questionnaire, foot function index and visual analogue scale. The Foot, 18(1), 15–19. https://doi.org/https://doi.org/10.1016/j.foot.2007.06.006
- Law, H., Neil, S. T., Dunn, G., & Morrison, A. P. (2014). Psychometric properties of the Questionnaire about the Process of Recovery (QPR). Schizophrenia Research, 156(2–3), 184–189. https://doi.org/https://doi.org/10.1016/j.schres.2014.04.011
- Leon, A. C., Shear, M. K., Klerman, G. L., Portera, L., Rosenbaum, J. F., & Goldenberg, I. (1993). A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression. Journal of Clinical Psychopharmacology, 13(5), 327–331. https://doi.org/https://doi.org/10.1097/00004714-199310000-00005
- Löwe, B., Kroenke, K., Herzog, W., & Gräfe, K. (2004). Measuring depression outcome with a brief self-report instrument: Sensitivity to change of the Patient Health Questionnaire (PHQ-9). Journal of Affective Disorders, 81(1), 61–66. https://doi.org/https://doi.org/10.1016/S0165-0327(03)00198-8
- McGlothlin, A. E., & Lewis, R. J. (2014). Minimal clinically important difference: Defining what really matters to patients. JAMA - Journal of the American Medical Association, 312(13), 1342. https://doi.org/https://doi.org/10.1001/jama.2014.13128
- Morosini, P. L., Magliano, L., Brambilla, L., Ugolini, S., & Pioli, R. (2000). Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning. Acta Psychiatrica Scandinavica, 101(4), 323–329. https://doi.org/https://doi.org/10.1034/j.1600-0447.2000.101004323.x
- Morrison, A. P., Law, H., Barrowclough, C., Bentall, R. P., Haddock, G., Jones, S. H., … Dunn, G. (2016). Psychological approaches to understanding and promoting recovery in psychosis and bipolar disorder: A mixed-methods approach. Programme Grants Appl Res, 4(5), 1–272. https://doi.org/https://doi.org/10.3310/pgfar04050
- Morrison, A. P., Law, H., Carter, L., Sellers, R., Emsley, R., Pyle, M., French, P., Shiers, D., Yung, A. R., Murphy, E. K., Holden, N., Steele, A., Bowe, S. E., Palmier-Claus, J., Brooks, V., Byrne, R., Davies, L., & Haddad, P. M. (2018a). Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: A randomised controlled pilot and feasibility study. The Lancet Psychiatry, 5(5), 411–423. https://doi.org/https://doi.org/10.1016/S2215-0366(18)30096-8
- Morrison, A. P., Pyle, M., Gumley, A., Schwannauer, M., Turkington, D., MacLennan, G., Norrie, J., Hudson, J., Bowe, S. E., French, P., Byrne, R., Syrett, S., Dudley, R., McLeod, H. J., Griffiths, H., Barnes, T. R. E., Davies, L., Kingdon, D., Aydinlar, S., Douglas-Bailey, M., … Tully, S. (2018b). Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): An assessor-blinded, randomised controlled trial. The Lancet Psychiatry, 5(8), 633–643. https://doi.org/https://doi.org/10.1016/S2215-0366(18)30184-6
- Morrison, A. P., Shryane, N., Beck, R., Heffernan, S., Law, H., McCusker, M., & Bentall, R. P. (2013). Psychosocial and neuropsychiatric predictors of subjective recovery from psychosis. Psychiatry Research, 208(3), 203–209. https://doi.org/https://doi.org/10.1016/j.psychres.2013.05.008
- Morrison, A. P., Turkington, D., Pyle, M., Spencer, H., Brabban, A., & Dunn, G. (2014). Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: A single-blind randomised controlled trial. The Lancet, 383(9926), 1395–1403. https://doi.org/https://doi.org/10.1016/S0140-6736(13)62246-1
- Nasrallah, H., Morosini, P. L., & Gagnon, D. D. (2008). Reliability, validity and ability to detect change of the personal and social performance scale in patients with stable schizophrenia. Psychiatry Research, 161(2), 213–224. https://doi.org/https://doi.org/10.1016/j.psychres.2007.11.012
- Neil, S. T., Kilbride, M., Pitt, L., Nothard, S., Nothard, S., Sellwood, W., & Morrison, A. P. (2009). The questionnaire about the process of recovery (QPR): A measurement tool developed in collaboration with service users. Psychosis, 1(2), 145–155. https://doi.org/https://doi.org/10.1080/17522430902913450
- NHS England, National Institute for Health and Care, & National Collaborating Centre for Mental Health Excellence. (2016). Implementing the early intervention in psychosis access and waiting time standard: Guidance, 57. https://www.england.nhs.uk/mentalhealth/wp-content/uploads/sites/29/2016/04/eip-guidance.pdf
- Pitt, L., Kilbride, M., Nothard, S., Welford, M., & Morrison, A. P. (2007). Researching recovery from psychosis: A user-led project. Psychiatric Bulletin, 31(2), 55–60. https://doi.org/https://doi.org/10.1192/pb.bp.105.008532
- Schennach, R., Obermeier, M., Seemüller, F., Jäger, M., Schmauss, M., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L. G., Gaebel, W., Klosterkötter, J., Heuser, I., Maier, W., Lemke, M. R., Rüther, E., Klingberg, S., Gastpar, M., Riedel, M., & Möller, H. J. (2012). Evaluating depressive symptoms in schizophrenia: A psychometric comparison of the calgary depression scale for schizophrenia and the hamilton depression rating scale. Psychopathology, 45(5), 276–285. https://doi.org/https://doi.org/10.1159/000336729
- Schunemann, H. J., & Guyatt, G. H. (2005). Commentary - Goodbye M(C)ID! Hello MID, where do you come from? Health Services Research, 40(2), 593–597. https://doi.org/https://doi.org/10.1111/j.1475-6773.2005.0k375.x
- Shanks, V., Williams, J., Leamy, M., Bird, V. J., Le Boutillier, C., & Slade, M. (2013). Measures of personal recovery: A systematic review. Psychiatric Services, 64(10), 974–980. https://doi.org/https://doi.org/10.1176/appi.ps.005012012
- Williams, J., Leamy, M., Pesola, F., Bird, V., Le Boutillier, C., & Slade, M. (2015). Psychometric evaluation of the Questionnaire about the Proces of Recovery (QPR). British Journal of Psychiatry, 207(6), 551–555. https://doi.org/https://doi.org/10.1192/bjp.bp.114.161695
- Wood, L., Price, J., Morrison, A., & Haddock, G. (2010). Conceptualisation of recovery from psychosis: A service-user perspective. The Psychiatrist, 34(11), 465–470. https://doi.org/https://doi.org/10.1192/pb.bp.109.027409
- Zaider, T. I., Heimberg, R. G., Fresco, D. M., Schneier, F. R., & Liebowitz, M. R. (2003). Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychological Medicine, 33(4), 611–622. https://doi.org/https://doi.org/10.1017/S0033291703007414
- Ziem, M., & Hoyer, J. (2019). Modest, yet progressive: Effective therapists tend to rate therapeutic change less positively than their patients. Psychotherapy Research, 30(4), 433–446. https://doi.org/https://doi.org/10.1080/10503307.2019.1631502